Monitor the Biomedical Evidence that Matters to You with Custom-Tailored Intelligence

Request a Demo
Posts From the monthly archives: "August 2015"

When we first launched BiomarkerBase, we put together a wishlist of meetings we’d like to attend to share our product and our company’s vision. It’s no surprise that the American Association of Clinical Chemistry (AACC) annual meeting was at the top of that list. We were finally able to make good on…(Read More)

During a recent panel discussion regarding the regulation of laboratory-developed tests (LDTs), Elizabeth Mansfield, Deputy Director for Personalized Medicine at FDA, announced that FDA will be increasingly focused on what she called “complementary diagnostics.” This category of tests will be distinct from companion diagnostics in that they will provide additional information about how a…(Read More)